OJEMDA 100 mg, film-coated tablet 20 tablets
Active ingredients: TOVORAFÉNIB
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OJEMDA 100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 20 comprimé(s)
- Marketing authorisation holder
- IPSEN PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63391676CIP73033749CIP133400930337493Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOVORAFÉNIBcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.